- The trend backdrop is active with a 7-week active streak.
- Price is above the Trend Line, keeping the weekly tape constructive.
- Price is above Fair Value, showing premium demand versus the model.
- Activity pressure is positive on the latest completed week.
LOR
GER
Week ended 07 Aug 2026
Weekly Investor Report
L'Oréal S.A. · Consumer Defensive · Household & Personal Products
Latest close
386.0 EUR
-0.3%
latest week
Weekly setup
Constructive, but selective
The weekly trend is active. Price is 3.9% above the Trend Line and sits at 77.8% of its 52-week range. The latest completed week returned -0.3%, after a 1.3% four-week move. The latest factor snapshot indicates quality ranks strongly versus its universe; growth is moderate; valuation is expensive relative to peers. The latest news-sentiment score is 50/100.
Setup score
50
out of 100
Latest Close
386.0 EUR
7 Aug 2026
1W Return
-0.3%
latest completed week
4W Return
1.3%
short-term follow-through
12W Return
8.2%
quarterly tape
Trend Breadth
34.6%
18 of 52 weeks active
Volume Ratio
1.4x
vs 13-week average
- No major top-level risk cluster is currently dominant.
- Price is close to its 52-week high; watch for continuation or exhaustion.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
-0.3%
Latest completed week; four-week move 1.3%.
Indicator stack
43/63
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
News sentiment
50/100
2 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is active. Price is 3.9% above the Trend Line and sits at 77.8% of its 52-week range. The latest completed week returned -0.3%, after a 1.3% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 1.4x the 13-week average. Participation is around or above normal and provides reasonable confirmation.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.6612-week average 0.38
12-week confirmation
Trend active7/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure10/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership4/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.66Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers
No recent accumulation markers. No reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is 1.3% over four weeks, 8.2% over 12 weeks, and 2.4% over one year. The current trend has remained active for 7 consecutive weeks.
Performance by holding period
Active trend streak7 weeks
Active weeks in one year18
Trend breadth34.6%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure0.75Latest activity-pressure read.
Pressure change-9.1%Four-week change in activity pressure.
Leadership-3.56Latest relative-leadership reading.
RS change-1580.0%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
The latest factor snapshot indicates quality ranks strongly versus its universe; growth is moderate; valuation is expensive relative to peers.
Factor week 09 Aug 2026
Financial statements through 31 Dec 2025
Field coverage 91%
Model confidence 72%
Relative factor standing
Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.
Overall factor strength22/100Blend of value, momentum, and quality. Underlying universe rank 79; rank 1 is best.
Value11/100Relative valuation strength. Underlying universe rank 90; rank 1 is best.
Quality92/100Profitability and accounting quality. Underlying universe rank 9; rank 1 is best.
Momentum38/100Medium-term price momentum. Underlying universe rank 63; rank 1 is best.
Growth26/100Revenue and earnings growth. Underlying universe rank 75; rank 1 is best.
Quality and valuation are separate questions
A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.
Valuation
How much investors are paying for earnings, sales, and cash flow.
- P/E
- 33.5x Price divided by trailing earnings.
- Price / sales
- 4.7x Market value relative to trailing revenue.
- EV / EBITDA
- 19.4x Enterprise value relative to operating cash earnings.
- Free-cash-flow yield
- 3.4% Free cash flow as a share of enterprise value.
Business quality
Margins and the return generated on invested capital.
- Gross margin
- 74.3% Gross profit retained from each unit of revenue.
- Operating margin
- 20.2% Operating profit retained from revenue.
- Free-cash-flow margin
- 16.3% Free cash flow generated from revenue.
- Return on invested capital
- 18.0% Operating return generated on invested capital.
Growth and financial strength
Recent business growth and accounting strength.
- Revenue growth
- 1.3% Latest one-year revenue growth.
- EPS growth
- -4.3% Latest one-year earnings-per-share growth.
- Free-cash-flow growth
- 7.8% Latest one-year free-cash-flow growth.
- Piotroski F-score
- 6/9 Nine-point accounting-strength checklist.
Shareholder return and balance sheet
Cash returned to owners and financial leverage.
- Dividend yield
- 1.9% Cash dividends relative to market value.
- Buyback yield
- 0.2% Net share repurchases relative to market value.
- Shareholder yield
- 2.1% Dividend yield plus net buyback yield.
- Net debt / EBITDA
- 0.2x Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment50/100
Weighted news tone is neutral across 2 relevant articles.
0 positive · 2 neutral · 0 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-3.7%Distance below the 52-week high.
13-week volatility2.6%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
13 Feb
13 Mar
10 Apr
8 May
5 Jun
3 Jul
7 Aug
Weeks higher11 of 2615 weeks finished lower.
Best week+7.7%Week of 20 Feb.
Worst week-6.6%Week of 6 Mar.
Latest week-0.3%Week of 7 Aug.
Shape of recent returns
Strong gains4
Modest gains7
Flat weeks0
Modest losses12
Sharp losses3
Recent vol2.6%13-week weekly-return volatility.
Base vol3.0%52-week weekly-return volatility.
Up/down split25/27Count of positive and negative weeks in the 52-week window.
Average skew2.5% / -2.1%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorDE Consumer Defensive
4-week rank19 / 38
Group average3.9%
Trend breadth50.0%
Trend50.0%active weekly trend signals
MD73.7%positive activity pressure
RS31.6%positive relative leadership
Four-week leaders
IndustryDE Household & Personal Products
4-week rank7 / 11
Group average1.6%
Trend breadth45.5%
Trend45.5%active weekly trend signals
MD90.9%positive activity pressure
RS27.3%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape47/100
Trend, activity pressure, participation, and risk combine to a 47/100 tape read.
Indicator analysis59/100Latest 12-week confirmation: trend 7/12, activity pressure 10/12, relative leadership 4/12.
Activity pressure 0.66; No reversal markers Factors40/100O'Shaughnessy factor stack blends value, quality, momentum, and confidence.
Buyback Yield rank 39 Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment50/100Weighted news tone is neutral across 2 relevant articles.
L'Oréal S.A. 2026 Q2 - Results - Earnings Call Presentation (NEOE:LOR:CA) 2026-07-30 Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 7 Aug 2026 | 386.0 EUR | -0.3% | 371.4 EUR | 374.9 EUR | 0.75 | -3.56 | 6.7K | On |
| 31 Jul 2026 | 387.1 EUR | 3.3% | 371.1 EUR | 375.0 EUR | 0.84 | -0.81 | 9.0K | On |
| 24 Jul 2026 | 374.6 EUR | -1.8% | 370.1 EUR | 375.0 EUR | 0.82 | -2.04 | 10.1K | On |
| 17 Jul 2026 | 381.5 EUR | 0.2% | 369.5 EUR | 375.1 EUR | 0.84 | 0.80 | 4.0K | On |
| 10 Jul 2026 | 381.0 EUR | -0.4% | 368.9 EUR | 375.2 EUR | 0.83 | -0.21 | 8.1K | On |
| 3 Jul 2026 | 382.4 EUR | -1.5% | 368.3 EUR | 375.3 EUR | 0.80 | -2.59 | 2.8K | On |
| 26 Jun 2026 | 388.1 EUR | 2.5% | 367.8 EUR | 375.3 EUR | 0.64 | 3.25 | 449 | On |
| 19 Jun 2026 | 378.8 EUR | -3.0% | 367.1 EUR | 375.4 EUR | 0.58 | -0.34 | 415 | Off |
| 12 Jun 2026 | 390.6 EUR | 4.0% | 366.3 EUR | 375.5 EUR | 0.36 | 4.22 | 1.6K | Off |
| 5 Jun 2026 | 375.5 EUR | -1.9% | 365.0 EUR | 375.5 EUR | 0.10 | -0.26 | 759 | Off |
| 29 May 2026 | 382.8 EUR | 5.9% | 364.1 EUR | 375.5 EUR | -0.01 | 0.24 | 6.3K | Off |
| 22 May 2026 | 361.6 EUR | 1.3% | 363.2 EUR | 375.6 EUR | -0.30 | -4.49 | 2.9K | Off |
| 15 May 2026 | 356.8 EUR | -1.5% | 363.4 EUR | 375.7 EUR | -0.32 | -2.19 | 9.5K | Off |
| 8 May 2026 | 362.4 EUR | -0.7% | 364.2 EUR | 376.0 EUR | -0.47 | -2.31 | 4.7K | Off |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.